(Q35597072)

9 August 2017

1 reference

title

Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients (English)

1 reference

9 August 2017

1 reference

1 reference

1 reference

N Kröger

1

1 reference

9 August 2017

L Damon

2

1 reference

9 August 2017

A R Zander

3

1 reference

9 August 2017

H Wandt

4

1 reference

9 August 2017

G Derigs

5

1 reference

9 August 2017

P Ferrante

6

1 reference

9 August 2017

T Demirer

7

1 reference

9 August 2017

G Rosti

8

1 reference

9 August 2017

Solid Tumor Working Party of the European Group for Blood and Marrow Transplantation

9

1 reference

9 August 2017

German Adjuvant Breast Cancer Study Group

10

1 reference

9 August 2017

University of California, San Francisco

11

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

Bone Marrow Transplantation

9 August 2017

published in

1 reference

9 August 2017

volume

32

1 reference

9 August 2017

issue

12

1 reference

9 August 2017

page(s)

1153-1157

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704291

9 August 2017

exact match

0 references

cites work

Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704291

Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704291

Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704291

Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704291

Low incidence of secondary myelodysplasia and acute myeloid leukemia after high-dose chemotherapy as adjuvant therapy for breast cancer patients: a study by the Solid Tumors Working Party of the European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704291

High-dose chemotherapy (CTM) for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704291

A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704291

Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704291

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704291

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704291

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704291

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704291

Risk of leukemia after chemotherapy and radiation treatment for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704291

7 January 2021

Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704291

7 January 2021

Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704291

7 January 2021

Balanced chromosome aberrations in leukemias following chemotherapy with DNA-topoisomerase II inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704291

7 January 2021

Cancer risk after adjuvant chemo- or chemohormonal therapy of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704291

7 January 2021

Acute myeloid leukemia following 3M (mitoxantrone, mitomycin and methotrexate) chemotherapy for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704291

7 January 2021

Secondary leukaemia after MMM combined modality therapy for breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704291

7 January 2021

Myelodysplasia and acute myeloid leukaemia following adjuvant chemotherapy for breast cancer using mitoxantrone and methotrexate with or without mitomycin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704291

7 January 2021

Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704291

7 January 2021

Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704291

7 January 2021

Increase therapy-related leukemia secondary to breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704291

7 January 2021

Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704291

7 January 2021

Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704291

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704291

1 reference

Dimensions Publication ID

9 August 2017

1044613884

0 references

1 reference